Search

Hung T Do

from Philadelphia, PA
Age ~41
Get Report
Also known as:
Jimmy Hung Do, Jimmy H Do, Hung Tdo, G Do, T Do
Related to:
Maihwa T DoBinh T Nguyen, 45Vinh H Nguyen, 64Mai DoCindy Do, 36Viet Nguyen, 69
Connected to:
Alexandra K Do, 84An D Do, 49Anh Q Do, 46Baophac P Do, 56Becky B Do, 59Bosco D Do, 42Carrie Do, 32Cho V Do, 73Chuan X Do, 61Chuyen M Do, 80

Hung Do Phones & Addresses

  • Philadelphia, PA
  • Garden Grove, CA
  • Atlanta, GA
  • Santa Ana, CA
  • Lawrenceville, GA
  • Lilburn, GA

Professional Records

Medicine Doctors

Hung Do Photo 1

Hung Kim Truong DO

View page
Specialties:
Internal Medicine
Cardiology
Hung Do Photo 2

Hung Dinh DO

View page
Specialties:
General Practice
Internal Medicine
Hung Do Photo 3

Hung Hoang Dang DO

View page
Specialties:
Emergency Medicine
Education:
A.T. Still University - Kirksville (2007)
Hung Do Photo 4

Hung Xuan Pham DO

View page
Specialties:
Emergency Medicine
Family Medicine
Internal Medicine
Education:
A.T. Still University - Kirksville (1996)
Hung Do Photo 5

Hung Trong Do

View page
Specialties:
General Practice
Education:
Faculty Mixte De Med Et De Pharm Univ De Saigon (1973)
Hung Do Photo 6

Hung Vu Do

View page
Specialties:
General Practice

Business Records

Name / Title
Company / Classification
Phones & Addresses
Hung Do
Owner
Irvine Teachers Supply & Children's Bookstore
Ret Educational Materials & Gifts · Offices of Dentists · Gift, Novelty, and Souvenir Stores
15415 Jeffrey Rd, Irvine, CA 92618
(949) 857-8989, (949) 654-5454
Hung Do
Executive Officer
Era Superior R.e.
500 Ml Rd, Bensalem, PA 19020
3933 Bristol Pike, Bensalem, PA 19020
(714) 375-3000

Publications

Us Patents

Compositions And Methods For The Expression Of Factor Viii Polypeptides And Uses Therefor

View page
US Patent:
6517830, Feb 11, 2003
Filed:
Aug 4, 2000
Appl. No.:
09/633020
Inventors:
John S. Lollar - Decatur GA
Hung V. Do - Atlanta GA
John F. Healey - Snellville GA
Edmund K. Waller - Atlanta GA
Assignee:
Emory University - Atlanta GA
International Classification:
A01N 6300
US Classification:
424 9321, 514 44, 4353201
Abstract:
Compositions and methods are provided for the in vivo gene delivery of nucleic acid sequences encoding the factor VIII protein to the liver endothelial sinusoidal cells (LSECs). Compositions and methods are also provided for the ex vivo gene transfer of nucleic acid sequences encoding the factor VIII protein to cultured LSECs and the implantation of the transformed LSECs in vivo. These methods and compositions increase the level of factor VIII in the blood stream and find use in the gene therapy treatment of hemophilia A.

Compositions And Methods For The Expression Of Factor Viii Polypeptides And Uses Therefor

View page
US Patent:
20030129174, Jul 10, 2003
Filed:
Dec 3, 2002
Appl. No.:
10/308637
Inventors:
John Lollar - Decatur GA, US
Hung Do - Atlanta GA, US
John Healey - Snellville GA, US
Edmund Waller - Atlanta GA, US
Assignee:
Emory University
International Classification:
A61K048/00
C12N005/08
C12N015/867
C12N015/861
US Classification:
424/093210, 435/456000, 435/366000
Abstract:
Compositions and methods are provided for the in vivo gene delivery of nucleic acid sequences encoding the factor VIII protein to the liver endothelial sinusoidal cells (LSECs). Compositions and methods are also provided for the ex vivo gene transfer of nucleic acid sequences encoding the factor VIII protein to cultured LSECs and the implantation of the transformed LSECs in vivo. These methods and compositions increase the level of factor VIII in the blood stream and find use in the gene therapy treatment of hemophilia A.

Therapy Regimens, Dosing Regimens And Stable Medicaments For The Treatment Of Pompe Disease

View page
US Patent:
20100119502, May 13, 2010
Filed:
Nov 11, 2009
Appl. No.:
12/616670
Inventors:
Hung V. Do - New Hope PA, US
Ken Valenzano - East Brunswick NJ, US
David J. Lockhart - Del Mar CA, US
Assignee:
AMICUS THERAPEUTICS, INC. - Cranbury NJ
International Classification:
A61K 38/47
A61P 43/00
US Classification:
424 9461
Abstract:
The present application provides a method for treating Pompe disease in a subject in need thereof, that includes a method of administering to the subject a GAA enzyme in combination with an ASSC for the GAA enzyme. The present application also provides methods for increasing the in vitro and in vivo stability of a GAA enzyme formulation.

Utilization Of Pharmacological Chaperones To Improve Manufacturing And Purification Of Biologics

View page
US Patent:
20110070643, Mar 24, 2011
Filed:
May 26, 2010
Appl. No.:
12/788068
Inventors:
Hung V. Do - New Hope PA, US
International Classification:
C12N 5/07
US Classification:
435357, 435375, 435358, 435367, 435369, 435365, 435354
Abstract:
The present invention provides methods for improving the production of recombinant proteins through the use of pharmacological chaperones for the recombinant proteins. As exemplified by the present invention, the binding of a pharmacological chaperone to a recombinant protein expressed by a cell can stabilize the protein and increase export of the protein out of the cell's endoplasmic reticulum, and increase secretion of the protein by the cell.

Utilization Of Pharmacological Chaperones To Improve Manufacturing And Purification Of Biologics

View page
US Patent:
20110143419, Jun 16, 2011
Filed:
Nov 22, 2010
Appl. No.:
12/952036
Inventors:
Hung V. Do - New Hope PA, US
International Classification:
C12N 9/26
C12N 9/42
US Classification:
435201, 435209
Abstract:
The present invention provides methods for improving the production of recombinant proteins through the use of pharmacological chaperones for the recombinant proteins. As exemplified by the present invention, the binding of a pharmacological chaperone to a recombinant protein expressed by a cell can stabilize the protein and increase export of the protein out of the cell's endoplasmic reticulum, and increase secretion of the protein by the cell.

Therapy Regimens, Dosing Regimens And Stable Medicaments For The Treatment Of Pompe Disease

View page
US Patent:
20110268721, Nov 3, 2011
Filed:
May 11, 2011
Appl. No.:
13/105720
Inventors:
Hung V. Do - New Hope PA, US
Ken Valenzano - East Brunswick NJ, US
David J. Lockhart - Solana Beach CA, US
Assignee:
Amicus Therapeutics, Inc. - Cranbury NJ
International Classification:
A61K 38/47
A61P 3/00
US Classification:
424 9461
Abstract:
The present application provides a method for treating Pompe disease in a subject in need thereof, that includes a method of administering to the subject a GAA enzyme in combination with an ASSC for the GAA enzyme. The present application also provides methods for increasing the in vitro and in vivo stability of a GAA enzyme formulation.

Method For Diagnosing Pompe Disease

View page
US Patent:
20120083010, Apr 5, 2012
Filed:
Aug 18, 2011
Appl. No.:
13/212917
Inventors:
Hung V. Do - New Hope PA, US
Brian E. Rane - Somerset NJ, US
John Flanagan - East Windsor NJ, US
International Classification:
C12Q 1/34
US Classification:
435 18
Abstract:
Provided is a method for diagnosing Pompe disease in a patient by measuring acid α-glucosidase activity in a sample from the patient. The invention also provides a method for monitoring the treatment of Pompe disease with specific pharmacological chaperones by measuring acid α-glucosidase activity in a sample from the patient.

Variant, Recombinant Beta-Glucocerebrosidase Proteins With Increased Stability And Increased Retained Catalytic Activity

View page
US Patent:
20130344054, Dec 26, 2013
Filed:
Nov 8, 2011
Appl. No.:
13/884126
Inventors:
Hung Do - New Hope PA, US
Assignee:
Callidus Biopharama, Inc. - Doylastown PA
International Classification:
C12N 9/24
US Classification:
424 9461, 435200, 536 232
Abstract:
Described herein are variant, recombinant β-glucocerebrosidase proteins characterized as having increased stability relative to recombinant wild-type β-glucocerebrosidase. Also provided herein are variant, recombinant β-glucocerebrosidase proteins characterized as retaining more catalytic activity relative to recombinant wild-type β-glucocerebrosidase. Further described herein are variant, recombinant β-glucocerebrosidase proteins that can have amino acid variations at one or more of the following positions: 316, 317, 321 and 145. Methods of making the variant, recombinant β-glucocerebrosidase proteins are also described as well as methods of treating patients having lysosomal storage diseases.
Control profile
Hung T Do from Philadelphia, PA, age ~41 Get Report